Travel grant to BIO KOREA 2026 in South Korea April 27-30 2026

Purpose and goal

With our unique AI/ML-based solution and demonstrated applicability and potential for Korean medicine and population and reduction of animal testing, we hope to be able to market, sell to newfound customers, find partners (e.g. for method development and expanded marketing and sales), and perhaps even investors, along the way. In the long term, we hope this will rationalize and reduce risks in Korean and Asian drug development and reduce the number of animal tests.

Expected effects and result

I expect/hope that it will create interest among those I meet and who take part in our methodology, but also that I will gain better insight into the Korean pharmaceutical world and their needs and opportunities. The aim is to become a visible player in the Korean market, to get new paying customers, possibly get a partner, and that new ideas and opportunities are born. Investor interest is welcome. We also want to rationalize Korean pharmaceutical development.

Planned approach and implementation

I have mapped the Korean medicine available on the market and started calling the pharmaceutical companies there and what their focus is. We have just submitted a manuscript to a journal where we specifically investigate the needs and opportunities there. When the list of participants becomes available, I will seek out and book f2f meetings where I will distribute our brochure and run a demo via laptop and try to generate interest and sales, etc.